Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases
US7255854B1 · kind B1 · utility
12Cited by
6References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 23, 1999 |
| Grant date | Aug 14, 2007 |
| Priority date | — |
| Expiry date | Apr 23, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods comprising “lymphotoxin-β receptor blocking agents” which block lymphotoxin-β receptor signaling and are useful for altering immunological diseases, and particularly antibody mediated immune responses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.